MedTrace Logo

Chronic Headache and Chronic Backache Following Unintentional Dural Puncture at Delivery Room.

NCT03908424 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 389

Last updated 2020-08-14

No results posted yet for this study

Summary

he study is a telephone questionnaire. The study will include 400 women, 100 in each group.

OBJECTIVE: To investigate the prevalence of chronic and chronic back pain following PDPH accidental dural puncture during epidyral analgesia for delivery.

1. Parturients who gave birth to a normal birth and did not receive epidural anesthesia.
2. Parturients who gave birth to a normal birth with epidural anesthesia without an unintentional dural puncture.
3. Parturients who gave birth to a normal birth with epidural anesthesia and had an unintentional dural puncture, these women were treated conservatively.
4. Parturients who had a normal birth with epidural anesthesia and had an unintentional dural puncture and were treated with a blood patch following PDPH.

Conditions

  • Parturient Who Underwent Epidural Anesthesia During Which an Unintentional Dural Punctur Occurred
  • Parturient Who Develop a Postdural Puncture Headache
  • Parturient Who Gave Informed Consent to Participation in the Study

Interventions

OTHER

Epidural Blood patch.

An epidural blood patch is a surgical procedure that uses autologous blood in order to close one or many holes in the dura mater of the spinal cord, usually as a result of a previous lumbar puncture. A small amount of the patient's blood is injected into the epidural space near the site of the original puncture; the resulting blood clot then "patches" the meningeal leak. An epidural needle is inserted into the epidural space at the site of the cerebrospinal fluid leak and blood is injected. The clotting factors of the blood close the hole in the dura.

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2020-08-11
Completion
2020-08-11

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03908424 on ClinicalTrials.gov